Login / Signup

New approaches to symptomatic treatments for Alzheimer's disease.

Jeffrey L Cummings
Published in: Molecular neurodegeneration (2021)
Advances in developing new agents for cognitive and behavioral symptoms of AD combined with enhanced trial methods promise to address the unmet needs of patients with AD for improved cognition and amelioration of neuropsychiatric symptoms.
Keyphrases
  • sleep quality
  • study protocol
  • clinical trial
  • phase iii
  • cognitive decline
  • mild cognitive impairment
  • randomized controlled trial
  • big data
  • white matter
  • multiple sclerosis
  • machine learning
  • double blind